尊龙凯时(中国大陆)-官方网站

THE 2024 Hetao Innovation Forum on biomedicine took place at the Hetao Innovation Center in Futian District on Novemberthe 25th.

At the forum, the University of Hong Kong-Shenzhen Hospital unveiled its Translational Medicine Research Center, and the Shenzhen Second People’s Hospital officially opened its Medical Innovation Technology Transfer Center.

Both centers are located in the Shenzhen park of the Hetao Shenzhen-Hong Kong Science and Technology Innovation Cooperation Zone.

The Translational Medicine Research Center will concentrate on four areas — oncology, reproductive health, orthopedic diseases, and rare diseases — and work to expedite the conversion of basic medical research findings into clinical applications.

The Medical Innovation Technology Transfer Center, an essential platform for the hospital’s transition to a high-level research facility, will focus on the research and development of advanced medical equipment, biomedical technology innovation, and cell and gene therapies.

Hua Haining, vice president of Shenzhen-Hong Kong Science and Technology Innovation Cooperation Zone Development Ltd., emphasized that the forum, along with the two new centers, are crucial strides for Shenzhen and Hong Kong in implementing the development outlines of Hetao.

Yesterday, the forum featured a keynote speech session and a dialogue session centered on building a biomedicine hub in Hetao. Today, a subforum on organs and organs-on-a-chip is taking place.

Situated on the border between Shenzhen and Hong Kong, Hetao, occupying a total area of 389 hectares, serves as a pioneering zone for enhancing technological collaboration between the two cities and acts as a nucleus for the transfer of technological breakthroughs within the Guangdong-Hong Kong-Macao Greater Bay Area.

Credit: Reporter Wang Jingli , Shenzhen Daily

Edited by HKU-SZH